Order Entry
United Kingdom
ContactUsLinkComponent
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK 2b/p38β2, respectively. Adezmapimod inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK 1 * 5 mg
Catalog # MDEXHY-10256
Supplier:  MEDCHEMEXPRESS
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK 2b/p38β2, respectively. Adezmapimod inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK 1 * 5 mg
Catalog # MDEXHY-10256
Supplier:  MEDCHEMEXPRESS
Frequently Bought Together